Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma

International Journal of Surgery

Volumn 6, Issue 4, 2008, Pages 293-297

  Neragi Miandoab, Siyamek ^a   Richards, William G ^b   Sugarbaker, David J ^b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Debulking; Epithelial histology; Malignant pleural mesothelioma; Palliative therapy; Sarcomatoid histology

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HISTOPATHOLOGY; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PLEURA BIOPSY; PLEURA MESOTHELIOMA; PLEURECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL RATE; THORAX RADIOGRAPHY; URINARY TRACT INFECTION; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CAUSE OF DEATH; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PLEURA; PLEURAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; THORACIC SURGERY, VIDEO-ASSISTED; THORACOTOMY; TIME FACTORS; UNITED STATES;

EID: 48349126422     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2008.04.004     Document Type: Article

References (29)

1. Antman K., Shemin R., Ryan L., Klegar K., Osteen R., Herman T., et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol 6 (1988) 147-153
2. Sugarbaker D.J., and Norberto J.J. Multimodality management of malignant pleural mesothelioma. Chest 113 (1998) 61S-65S
3. Rusch V., Saltz L., Venkatraman E., Ginsberg R., McCormack P., Burt M., et al. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 12 (1994) 1156-1163
4. Hilaris B.S., Nori D., Kwong E., Kutcher G.J., and Martini N. Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 10 (1984) 325-331
5. Pass H.I., Temeck B.K., Kranda K., Steinberg S.M., and Feuerstein I.R. Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 115 (1998) 310-317 [discussion 317-8]
6. Brancatisano R.P., Joseph M.G., and McCaughan B.C. Pleurectomy for mesothelioma. Med J Aust 154 (1991) 455-457 460
7. Rusch V.W. Clinical features and current treatment of diffuse malignant pleural mesothelioma. Lung Cancer 12 Suppl. 2 (1995) S127-S146
8. Boylan A.M. Mesothelioma: new concepts in diagnosis and management. Curr Opin Pulm Med 6 (2000) 157-163
9. Rusch V.W., and Venkatraman E.S. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 68 (1999) 1799-1804
10. Rusch V.W. Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 9 (1997) 367-372
11. Achatzy R., Beba W., Ritschler R., Worn H., Wahlers B., Macha H.N., et al. The diagnosis, therapy and prognosis of diffuse malignant mesothelioma. Eur J Cardiothorac Surg 3 (1989) 445-447 [discussion 448]
12. Soysal O., Karaoglanoglu N., Demiracan S., Topcu S., Tastepe I., Kaya S., et al. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg 11 (1997) 210-213
13. Aziz T., Jilaihawi A., and Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 22 (2002) 298-305
14. de Vries W.J., and Long M.A. Treatment of mesothelioma in Bloemfontein, South Africa. Eur J Cardiothorac Surg 24 (2003) 434-440
15. Martin-Ucar A.E., Edwards J.G., Rengajaran A., Muller S., and Waller D.A. Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. Eur J Cardiothorac Surg 20 (2001) 1117-1121
16. Merritt N., Blewett C.J., Miller J.D., Bennett W.F., Young J.E., and Urschel J.D. Survival after conservative (palliative) management of pleural malignant mesothelioma. J Surg Oncol 78 (2001) 171-174
17. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., Richards W.G., Strauss G.M., Corson J.M., et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117 (1999) 54-63 [discussion 63-5]
18. Moskal T.L., Dougherty T.J., Urschel J.D., Antkowiak J.G., Regal A.M., Driscoll D.L., et al. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann Thorac Surg 66 (1998) 1128-1133
19. Musk A.W., and Woodward S.D. Conventional treatment and its effect on survival of malignant pleural mesothelioma in Western Australia. Aust N Z J Med 12 (1982) 229-232
20. Ruffie P., Feld R., Minkin S., Cormier Y., Boutan-Laroze A., Ginsberg R., et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 7 (1989) 1157-1168
21. Law M.R., Gregor A., Hodson M.E., Bloom H.J., and Turner-Warwick M. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax 39 (1984) 255-259
22. Hulks G., Thomas J.S., and Waclawski E. Malignant pleural mesothelioma in western Glasgow 1980-6. Thorax 44 (1989) 496-500
23. Halstead J.C., Lim E., Venkateswaran R.M., Charman S.C., Goddard M., and Ritchie A.J. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Eur J Surg Oncol 31 (2005) 314-320
24. Ceresoli G.L., Locati L.D., Ferreri A.J., Cozzarini C., Passoni P., Melloni G., et al. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer 34 (2001) 279-287
25. Pass H.I., Kranda K., Temeck B.K., Feuerstein I., and Steinberg S.M. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol 4 (1997) 215-222
26. Lucchi M., Chella A., Melfi F., Dini P., Ambrogi M., Fino L., et al. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma. Eur J Cardiothorac Surg 31 (2007) 529-533 [discussion 533-4]
27. Flores R.M., Pass H.I., Seshan V.E., Dycoco J., Zakowski M., Carbone M., et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135 (2008) 620-626 e621-3
28. Okada M., Mimura T., Ohbayashi C., Sakuma T., Soejima T., and Tsubota N. Radical surgery for malignant pleural mesothelioma: results and prognosis. Interact Cardiovasc Thorac Surg 7 (2008) 102-106
29. Schipper P.H., Nichols F.C., Thomse K.M., Deschamps C., Cassivi S.D., Allen M.S., et al. Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg 85 (2008) 257-264 [discussion 264]